Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis

NCT00831974 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Mastocytosis

Interventions

DRUG: masitinib (AB1010)
DRUG: masitinib (AB1010)

Sponsor

AB Science